FILE – The overdose-reversal drug Narcan is displayed during training for employees of the Public Health Management Corporation (PHMC), Dec. 4, 2018, in Philadelphia. The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, Wednesday, March 29, 2023, marking the first time a opioid treatment drug will be available without a prescription. (AP Photo/Matt Rourke, File)

The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time an opioid treatment drug will be available without a prescription. Wednesday’s approval is for Narcan, a name-brand version of naloxone sold by Emergent BioSolutions. How much this will impact a nationwide overdose crisis is not clear, even though better access to naloxone is a priority. The decision means Narcan can be available at convenience and grocery stores, but its price isn’t clear. For many people who use drugs, naloxone is already available from community groups — and that’s not expected to change.